Virtual Press Conference: Pediatric COVID-19 Vaccines – 6/17/2022
Join us for a virtual press conference to discuss the FDA’s emergency use authorization of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include use in children down to six months of age. FDA Commissioner Dr. Robert M. Califf and FDA's Center for Biologics Evaluation and Research Director Dr. Peter Marks will be taking questions.
